GlaxoSmithKline Pharmaceuticals has informed that the Company has received a Demand Notice dated 24th June 2026 from the National Pharmaceutical Pricing Authority. The relevant details to be disclosed are enclosed.
The above information is a part of company’s filings submitted to BSE.